FindTrial
Sign In

Major depression in Borderline Personality disorder: A distinct clinical presentation?

Clinical features of Major depression in patients with and without Borderline personality disorder: A cross sectional observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053617
Enrollment
72
Registered
2023-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: F603- Borderline personality disorder Health Condition 3: F30-F39- Mood [affective] disorders

Interventions

Intervention1: NIL: NIL Control Intervention1: Major depressive disorder with co-morbid Borderline personality disorder (GROUP A): Patients fulfilling the diagnosis of Borderline personality disord

Sponsors

Department of Psychiatry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: GROUP A 1.Diagnosis of Borderline Personality disorder as per DSM-5. 2.Diagnosis of Major depressive disorder as per DSM-5. 3.Age between 18-35yrs 4.Written informed consent for study GROUP B 1.Diagnosis of Major depressive disorder as per DSM-5. 2.Age between 18-35 years. 3.Written informed consent.

Exclusion criteria

Exclusion criteria: Group A 1.Diagnosis other than Major depressive disorder and/or Borderline personality disorder as per DSM-5 criteria. 2.Diagnosis of substance use-disorder except caffeine and/or Nicotine use disorder as per DSM-5 3.Diagnosis of medical disorder causing/mimicking depression Group B 1.Diagnosis other than Major depressive disorder as per DSM-5. 2.Diagnosis of substance-use disorder except caffeine and/or Nicotine-use disorder as per DSM-5. 3.Diagnosis of medical disorder causing/mimicking depression.

Design outcomes

Primary

MeasureTime frame
Comparison of Clinical profile of Major depressive disorder in patients with Borderline personality disorder and without Borderline personality disorder.Timepoint: BASELINE—

Secondary

MeasureTime frame
Anxiety symptoms in the two groups (Hamilton anxiety rating scale(Clinician rated)-CROSS SECTIONAL)Timepoint: BASELINE;Core-features of Major depressive disorder in the two groups ( Using Inventory of depressive symptomatology (IDS-30-Clinician rated) CROSS-SECTIONALTimepoint: BASELINE;Psychomotor functioning-Non-interactiveness, retardation and agitation (Using CORE assessment for psychomotor change scale(Clinician rated)-CROSS-SECTIONALTimepoint: BASELINE;Self-harm behavior in the two groups ( Using Self-harm inventory self-rated scale-CROSS SECTIONAL)Timepoint: BASELINE;Somatic symptoms in the two groups (Somatoform disorders symptoms checklist CROSS-SECTIONALTimepoint: BASELINE;Suicidality in the two groups (Columbia suicide severity rating scale CROSS SECTIONAL)Timepoint: BASELINE—

Countries

India

Contacts

Public ContactHarkunwar Singh Sidhu

Kasturba Medical college Manipal

ravindra.nm@manipal.edu9972028881

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026